International Cancer Research Conference
March 24-26, 2025 | Singapore
Cancer Imaging Techniques
In all stages of cancer treatment, a variety of biomedical imaging techniques are used. Imaging is an important aspect of cancer treatment procedures because it can provide morphological, structural, metabolic, and functional data. Despite breakthroughs in many areas of diagnostic radiology, human cancer detection and imaging remain a concern. Biomedical imaging is becoming increasingly relevant in all stages of cancer management. Clinical decision-making is assisted by integration with other diagnostic technologies such as in vitro tissue and fluid analyses. Early diagnosis of cancer using imaging-based screening is likely the most important factor in lowering mortality rates for some cancers. Prediction screening, biopsy advice for detection, staging, prognosis, therapy planning, therapy guidance, therapy response, recurrence, and palliation are some of the options included under biomedical imaging.
- X-ray
- Computed tomography (CT) scan
- Ultrasound (US)
- Magnetic resonance imaging (MRI)
- Single-photon emission computed tomography (SPECT)
- Positron emission tomography (PET)
- Optical imaging
- Biomarker based detection technique
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Jianhua Luo
University of Pittsburgh, United States
Kaushala Prasad Mishra
Asian Association for Radiation Research (AARR), India
Mariola Wioletta Borowska
Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Ibrahim El Bayoumy
Tanta faculty of medicine, Kuwait
Andrea González Báez
Autonomous University of Nuevo Leon, MexicoSubmit your abstract Today
Title :
Pietro Salvatori, Private Practice, Italy
Title :
Jianhua Luo, University of Pittsburgh, United States
Title :
Marika Crohns, Sanofi, Germany
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom